We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current EXL market cap is 2.85M. The company's latest EPS is AUD -0.0119 and P/E is 0.00.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 32.47M | 15.6M | 11.76M | 7.57M | 8.83M |
| Operating Income | -88.6M | -100M | -17.05M | -10.51M | -7.62M |
| Net Income | -82.93M | -104.51M | -17.03M | -10.57M | -7.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 121.07M | 42.47M | 25.33M | 13.49M | 11.71M |
| Total Liabilities | 9.69M | 6.82M | 6.26M | 4.33M | 5.25M |
| Total Equity | 111.38M | 35.65M | 19.08M | 9.16M | 6.46M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -51.07M | -22.62M | -14.07M | -8.15M | -2.76M |
| Investing | -17.93M | 2.55M | 172k | -869k | -1.04M |
| Financing | 46.44M | 27.55M | -1.16M | -757k | 1.61M |
| Market Cap | 2.85M |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 632.87M |
| Average Volume (1 week) | 980.85k |
| Average Volume (1 Month) | 5.05M |
| 52 Week Change | -76.32% |
| 52 Week High | 0.02 |
| 52 Week Low | 0.004 |
| Spread (Intraday) | 0 (20%) |
| Company Name | Elixinol Wellness Limited |
| Address |
level 12 sydney, new south wales 2000 |
| Website | https://elixinolglobal.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
